# 68025-089-30 · Methylphenidate Hydrochloride Tablet, Extended Release · Vertical Pharmaceuticals, LLC — FDA drug shortage duration tracker

For 68025-089-30 · Methylphenidate Hydrochloride Tablet, Extended Release · Vertical Pharmaceuticals, LLC, package ndc is 68025-089-30; generic name is Methylphenidate Hydrochloride Tablet, Extended Release; manufacturer is Vertical Pharmaceuticals, LLC; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 68025-089-30 _(verified: appears in the quote below)_
- **Generic name:** Methylphenidate Hydrochloride Tablet, Extended Release _(verified: appears in the quote below)_
- **Manufacturer:** Vertical Pharmaceuticals, LLC _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 07/26/2023 _(verified: appears in the quote below)_
- **Last update date:** 08/17/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1133 _(our reading, not quoted from the source)_
- **Dosage form:** Tablet _(verified: appears in its own passage below)_
- **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "07/26/2023", "package_ndc": "68025-089-30", "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release", "contact_info": "800-541-4802", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)", "company_name": "Vertical Pharmaceuticals, LLC", "status": "Current"

### Status

> "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)", "company_name": "Vertical Pharmaceuticals, LLC", "status": "Current"

### Last update date

> "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)", "company_name": "Vertical Pharmaceuticals, LLC", "status": "Current"

### Dosage form

> "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)", "company_name": "Vertical Pharmaceuticals, LLC", "status": "Current"

### Therapeutic category

> "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)", "company_name": "Vertical Pharmaceuticals, LLC", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).